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Abstract: The Human Papillomavirus (HPV) vaccine has the great potential to prevent HPV-related
infections for millions of women and men worldwide. However, the success of the vaccine is highly
dependent on the vaccination rate. Factors influencing the attitudes of undergraduate students
towards HPV vaccination should be studied. This is a cross-sectional survey that was conducted to
estimate the HPV vaccination rate among undergraduate students in Hong Kong, and to identify the
predictors of their attitude towards HPV vaccination. The results showed that the HPV vaccination
rate was 13.3%. Factors related to knowledge of vaccination were the main predictors of the students’
attitude towards vaccination (there were seven predictors, with B = 1.36 to 2.30; p < 0.05), followed
by gender (B = ´1.40; p < 0.05), acceptable maximum price (B = 0.35; p < 0.05), and willingness to
receive the HPV vaccine if it can protect against cervical/anal cancer and genital warts (B = ´1.90;
p < 0.001). The regression model that was developed based on the predictors had a moderate effect
size (adj-R2 = 0.33). To conclude, the HPV vaccination rate among undergraduate students in Hong
Kong was low. They should be provided with more active education and activities to promote HPV
vaccination to improve their knowledge on the subject.
Keywords: HPV; papillomavirus; undergraduate students; vaccination
1. Introduction
The Human Papillomavirus (HPV) is one of the main causes of anogenital warts and cervical
cancer [1]. It is the eighth most common form of cancer among Hong Kong women, with a prevalence
rate of 11.9 per 100,000 women. It is especially common in women aged between 20 and 44, accounting
for 7.9% of all cancers in this demographic [2]. HPV is transmissible through sexual contact, including
by having vaginal, anal, or oral sex with an infected person [3]. The Centre for Health Protection
reported that the prevalence of HPV in Hong Kong is between 7% and 11% for those attending
a cervical screening service [4]. Regular cervical screening and HPV vaccination are the usual means
for the early detection or prevention of HPV-related diseases.
It is believed that HPV vaccines can effectively protect the recipient against such HPV-related
diseases as cervical cancer, vaginal cancer, vulvar cancer, and genital warts [5]. The HPV vaccination
rate of women in the USA and Australia is about 37.6% and 32%, respectively [6], but it is lower
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in Asian countries. Two types of HPV vaccines have been available in Hong Kong since 2009—the
quadrivalent and bivalent HPV vaccines. The Center for Disease Control and Prevention has suggested
that people can receive the vaccine starting from the age of nine. Females and males can receive the
vaccine until the ages of 26 and 21, respectively [7]. Several programs have been carried out in Hong
Kong to promote HPV vaccination, such as the “Youth HPV prevention program” organized by the
Society of Physicians of Hong Kong. The aim of this program was to raise awareness of HPV and
related diseases. The target groups of this program were full-time primary and secondary school
students in Hong Kong, aged nine or above who had never before received the HPV vaccination before.
Two or three doses of vaccine will be given depending on the age of the participant. Currently, a “2-in-1
vaccine” (HPV type 16 and 18) and a “4-in-1 vaccine” (HPV type 6, 11, 16, and 18) are provided at
a price of HK$700 per dose, excluding the doctor’s and nurse’s free [8]. However, among adolescent
girls it is only 7.5% [9], while in a more recent study, the vaccination rate for girls under 18 was reported
to be even 2.4% [10]. Although Hong Kong adolescent girls have a generally favorable attitude towards
HPV vaccination and HPV programs are promoted widely in Hong Kong through different mass
media, the vaccination rate is relatively low compared to that in other developed countries [10,11].
1.1. Attitude on Vaccination
There are many studies investigating the perceptions of adolescent girls of the risk of contracting
diseases related to HPV, the effectiveness and safety of the HPV vaccine, and their intention to receive
the HPV vaccination [12]. According to Kwan et al. [11], despite the low HPV vaccination rate in Hong
Kong, local women and adolescent girls generally held a favorable attitude towards HPV vaccination.
The result of a local study targeting adolescent girls aged between 13 and 21 showed that the majority
of the participants thought that cervical cancer was a terrible disease and were willing to take action
to prevent its occurrence. Although one-third of the participants wanted to be vaccinated against
HPV, nearly 60% of the participants were still in the stage of contemplation, and only about 6.7% of
them had actually received the vaccination [13]. This suggests that apart from the perceived risk of
contracting cervical cancer, there were other factors affecting the decision of adolescent girls to be
vaccinated against HPV that require further exploration.
Regarding studies on male attitudes, these have mostly been conducted in foreign countries.
One of the studies conducted by Songthap et al. investigated the attitudes of male college students in
Thailand towards HPV vaccination [14]. The results showed that about 65% of the participating males
agreed that it was important to be vaccinated against HPV before becoming sexually active. Both the
male and female participants agreed that cervical cancer could cause death in women, and that they
should take the vaccination. However, only 25.3% of them were willing to do so. There is no local
study on HPV vaccination that specifically targets adolescent males.
1.2. The Acceptability of Vaccination
Acceptance of the HPV vaccine might be influenced by factors affecting the decision-making
process that individuals go through when deciding whether or not to be vaccinated. Several local
studies have consistently suggested that the cost of the HPV vaccines is a major barrier to their
acceptance by mothers and female adolescents [9–11,15,16]. The median price that mothers were
willing to pay for a full-course of vaccination was HK$1000, substantially lower than the current market
price [10]. Apart from the concern over cost, for parents the barriers to vaccination include uncertainty
over the side effects of the vaccine such as infertility [17–20], the duration of the effectiveness of
the vaccine, the perception that the risk of becoming infected with HPV is low, the perception that
there is no immediate need for vaccination, the anticipation of family disapproval, and the fear of
experiencing pain during injections [11]. Other factors included the fear that receiving the vaccination
would cause daughters to engage in riskier sexual behavior [21–25], and religious proscriptions against
engaging in sexual activities before marriage [26]. By contrast, the factors facilitating acceptance of
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HPV vaccination include perceived support from family and peers, medical assurances of the safety
and efficacy of the vaccine [11], and recommendation of the vaccine by professionals [20].
1.3. Knowledge of Vaccination
A local study found that young teenage girls aged 13–20 had a limited knowledge of HPV and
its relationship with cervical cancer [11]. For example, they had difficulty in understanding the
mechanism linking HPV infection with cervical cancer. Another study in Thailand showed that 73.8%
of male students and 69.6% of female students aged 12–15 did not know who should be screened for
cervical cancer [14]. Furthermore, the study of Bowyer et al. in England indicated that more than 50%
of girls aged 15–16 had little knowledge about HPV, the vaccine, and the need for future screening,
even if they had been vaccinated [27]. Female undergraduate students in Korea and Nigeria were also
found to be insufficiently knowledgeable about HPV and vaccination [28,29]. Reimer et al. also noted
that among whites and Hispanics, males were less aware and knowledgeable about HPV and the HPV
vaccine than females [30]. There have been a number of studies focusing on female knowledge of HPV
and the vaccine, but a paucity of studies on the knowledge of males.
1.4. Research Gaps and Aim/Purpose of the Study
There have been many studies investigating the attitudes of school students and their parents
toward HPV vaccination, but research focusing on young adults is limited [11,13,14]. According to
a study on youth sexuality conducted in 2011 by The Family Planning Association of Hong Kong,
around half of young adults aged between 18 and 27 had sexual experience. Nearly 3% of them had
their first experience before the age of 16 [31]. The aim of this study was to explore the perceptions of
university students from Hong Kong towards HPV and HPV vaccination, in terms of their attitudes,
acceptance, and knowledge. The objectives were to identify the underlying factors that might affect the
attitudes of the university students, and to compare the attitudes and knowledge of male and female
students on HPV vaccination. The results of the study provided findings and insights that will allow
researchers and public health professionals to better promote and continue to conduct research on
HPV vaccination for young adults, particularly males; and over a longer term to achieve better control
of the diseases related to HPV.
2. Materials and Methods
2.1. Study Design
This is a cross-sectional survey that was conducted in a major university in Hong Kong from
April to September 2015.
2.2. Sampling Method
Convenience sampling was conducted to recruit subjects for this study. There was no special
event or news related to HPV according to the press releases issued in the study period by the Centre
of Health Protection and the Department of Health. The selected university has 18,777 undergraduate
students, 13,954 of whom were enrolled in publicly funded programs. These students constitute
17.25% of the total number of publicly funded undergraduate students in Hong Kong. The result
of the sample size calculation showed that at least 377 students are required to keep the margin of
error within 5% and the confidence level at 95% [32]. A set of questionnaires in paper format was
distributed to students and collected during their lectures, while some questionnaires were completed
by students randomly selected on campus during school days. The students were given no incentives
to participate in the survey.
2.3. Inclusion and Exclusion Criteria
The criteria for inclusion were: (1) undergraduate students studying in the selected university;
and (2) capable of communicating in English. The criteria for exclusion were: (1) undergraduate
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students under the age of 18; (2) students from Mainland China and overseas; and (3) undergraduate
students 25 years of age or older. Students from Mainland China were excluded because they only
comprised around 8% of the undergraduate students in the university [33]. Moreover, from the view of
health policy, the priority should be on local students because they are expected to stay and contribute
to Hong Kong in the long run.
2.4. Instrument
The set of questionnaires used in this study was modified from a study conducted by a Thai
research team that was also investigating similar issues among Thai students [14]. The eight-page
questionnaire is designed to collect data on the university students in four areas: (1) Basic information
on their socio-demographic and medical backgrounds (17 items); (2) Their knowledge of HPV, cervical
cancer, and the HPV vaccine (22 items). Each question has three possible options (Yes/No/Don’t
know); the option of “don’t know” is considered an incorrect answer; (3) Attitude towards HPV,
cervical cancer, and the HPV vaccine (21 items). The items are in a 5-point Likert scale from 1 “strongly
disagree” to 5 “strongly agree”; (4) Acceptability of the HPV vaccine (6 items). The questions relate to
the students’ preferred place and price for receiving the HPV vaccination, and to their belief of which
group of people should be vaccinated against HPV. Overall, the scale-level content validity index of
the questionnaire was found to be 0.92, which is an acceptable level [34].
2.5. Data Analysis
Descriptive statistics were used to identify a general picture of the demographics and medical
backgrounds of the students, and their attitudes, knowledge, and acceptance of HPV vaccination.
To compare gender differences in the students’ attitude and knowledge of HPV vaccination,
an independent sample t-test was adopted because only two groups of students were involved
in this cross-sectional study. Finally, through a bivariate analysis, the students’ socio-demographic
and medical backgrounds, and their acceptance and knowledge of HPV vaccination were correlated
with their total score on their attitude towards HPV vaccination. Potential predictors with a p-value of
smaller than 0.1 found in the bivariate analysis were further analyzed using multivariate regression
analysis, in order to further confirm the significant predictors of the students’ attitude towards HPV
vaccination. All of the statistical analyses were conducted using SPSS version 23 (IBM, Armonk, NY,
USA). The alpha level was set at 0.05.
2.6. Ethical Considerations
Before completing the questionnaires, the subjects were well informed about the purpose and
contents of the study. They were given an information sheet and asked to sign a consent form to
document their voluntary participation. They were also informed that their participation was totally
voluntary and that they had the right and freedom to withdraw from the study at any time without




A total of 520 sets of questionnaires were distributed; 437 sets of completed questionnaires were
collected, for a response rate of 84%.
3.2. Socio-Demographic Characteristics
Table 1 shows that around half of the subjects were male (46.5%) and enrolled in
a healthcare-related program (53.1%). Two-thirds of them were aged 18–21 (66.6%). The majority of
the subjects had a monthly income of less than HK$3000 (67.3%). Most of them were living with family
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(90.4%) and were without any religious beliefs (72.4%). Around two-thirds of them were single (63.2%),
while the remaining one-third were in a relationship with one person (36.4%), with the exception of
two subjects (0.5%), who were in relationships with more than one person. Only one-fifth of them had
sexual experience (17%).





Program Related to healthcare 232 (53.1)
Not related to healthcare 205 (46.9)








Live with family 395 (90.4)
Shared Dormitory 31 (7.1)










In a relationship with 1 person 159 (36.4)
In a relationship with >1 person 2 (0.5)
Had Sexual Experience 73 (17.0)
3.3. Health-Related Characteristics
The estimated vaccination rate was 13.3%, with the female vaccination rate (24.4%) being
significantly higher than that of the male (0.5%). Virtually all of the participants had no history
of cervical cancer (100%), genital warts (99.5%), or anal cancer (99.8%). Around 90% of them had heard
about cervical cancer (87.9%) and the HPV vaccine (92.2%), with television being the main source of
this information (around 75%), followed by the Internet, newspapers/magazines, and their healthcare
provider (all slightly more than 40%). More than two-thirds of them stated that they would like to be
vaccinated if the HPV vaccine can protect them against cervical/anal cancer and genital warts (69.6%),
while one-fifth of them were unwilling to be vaccinated (19.5%) (Table 2).
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Table 2. Medical background.
Variable n (%)
History of genital warts 2 (0.5)
History of anal cancer 1 (0.2)
History of cervical cancer 0 (0)
Heard about cervical cancer 384 (87.9)









Heard about the HPV vaccine 403 (92.2)













Willingness to receive the HPV vaccine
if it can protect against cervical/anal
cancer and genital warts
Would like to be vaccinated 300 (69.6)
Would not like to be vaccinated 84 (19.5)
Cannot make a decision 47 (10.9)
3.4. Acceptability of HPV Vaccination
Near half of the subjects preferred to be vaccinated at the health clinic of a university (43.2%)
followed by a public hospital (34.1%). Of the participants, 77.6% believed that both males and females
should get the vaccination equally if the HPV vaccine can protect against both cervical cancer and
genital warts, while only 22% of them believed that “only females” or “females should get the vaccine
rather than males”. If the HPV vaccine is beneficial for adolescents who are not sexually active, most
of the respondents believed the ideal age for vaccination to be between the ages of 11 and 18, with
15–16 years old being the age range chosen by the largest percentage of respondents (26.8%) (Table 3).
Regarding expectations of the appropriate price for HPV vaccination, most of the respondents
chose the lowest price option (<$500). Regardless of the efficacy of the vaccine, the proportion of
respondents who indicated that the price was acceptable decreased as the price increased (Figure 1a,b).
The pattern was slightly different for the maximum acceptable price. When the efficacy of the vaccine
was sufficiently high, the respondents were willing to pay a higher price (Figure 1c,d). For instance,
when the efficacy of the vaccine in preventing both cervical cancer and genital warts was 100%, most
of the respondents replied that the maximum affordable price was $901–$1100. The proportion of
respondents who chose $1301–$1500 was even larger than the group that chose <$500 (Figure 1d).
Int. J. Environ. Res. Public Health 2016, 13, 486 7 of 16
Int. J. Environ. Res. Public Health 2016, 13, 486 7 of 15 
 
 
Figure 1. Respondents’ expectations of the appropriate and maximum prices for HPV vaccine. (a) Respondents’ expectations of the appropriate price for the HPV 
vaccine against cervical cancer; (b) Respondents’ expectations of the appropriate price for the HPV vaccine against cervical cancer and genital warts. (c) 
Respondents’ acceptable maximum price for the HPV vaccine against cervical cancer; (d) Respondents’ acceptable maximum price for the HPV vaccine against 
cervical cancer and genital warts. 
Figure 1. Respondents’ expectations of the ap ropriate and maxi i f vaccine. (a) Respondents’ expectations of the appropriate price for the HPV
vaccine against cervical c ncer; (b) Respondents’ expectations of the appropriate price for the HPV vaccine against cervical cancer an it l rts. (c) Respondents’
acceptable maximum rice for the HPV vaccine against cervical cancer; (d) Respo dents’ acce table maximum price for the HPV vaccine against cervical cancer and
genital warts.
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Table 3. Students’ acceptance of HPV vaccination.
Variables n (%)
If the HPV vaccine is available and
deliverable in the places listed below, which
option would make it more likely that you
would go to get vaccinated against HPV?
Health clinics in universities 189 (43.2)
Public hospitals 149 (34.1)
General practitioners 97 (22.2)
Private hospitals 63 (14.4)
If the HPV vaccine can protect against both
cervical cancer and genital warts, who
should get the vaccination?
Both males and females should get
vaccinated equally 339 (77.6)
Females should get it rather than males + 68 (15.6)
Females only 28 (6.4)
Males only 2 (0.5)
Males should get it rather than females ++ 0 (0)
If the HPV vaccine is beneficial for
adolescents who are not sexually active,
which of the following would be the ideal
age for vaccination?
15–16 years old 117 (26.8)
17–18 years old 97 (22.2)
13–14 years old 95 (21.7)
11–12 years old 79 (18.1)
ď10 years old 45 (10.3)
>18 years old 4 (0.9)
+ This option means that getting vaccinated is much more important for females than males. ++ This option
means that getting vaccinated is much more important for males than females.
3.5. Attitude towards HPV Vaccination
Regarding the respondents’ attitude towards HPV vaccination, most of the statements received
a rating higher than the middle score (i.e., 3), with the exception of the following four statements:
“(1) I think I can be easily infected by HPV” (Mean score: 2.24; SD: 0.96); “(4) People with only one
sexual partner have a low risk of getting infected with HPV” (Mean score: 2.64; SD: 1.01); “(11) Women
are embarrassed to get a Pap test” (Mean score: 2.91; SD: 1.00); and “(20) I need extra information
about the efficacy of the vaccine” (Mean score: 2.14; SD: 0.80) (Table 4).
Statistically significant gender differences were observed for four statements, but the differences
of the scores were smaller than 0.5, which cannot be considered clinically significant. The statements
were: “(8) Cervical cancer is not a big problem for women” (p < 0.05); “(11) Women are embarrassed to
get a Pap test” (p < 0.05); “(12) HPV vaccination is not necessary because a Pap test can be done to rule
out cervical cancer” (p < 0.01); and “(13) It is better to be vaccinated before becoming sexually active”
(p < 0.05) (Table 4).
Table 4. Gender differences in attitude towards HPV vaccination.
Questions on Attitude towards HPV Vaccination
Males Females Total
t-Statistics
Mean (SD) Mean (SD) Mean (SD)
(1) I think I can be easily infected by HPV 2.15 (1.02) 2.32 (0.89) 2.24 (0.96) ´1.84
(2) I think HPV infection is a serious disease 4.03 (0.87) 4.04 (0.73) 4.04 (0.80) ´0.05
(3) Preventing HPV infection is important for women 4.25 (0.78) 4.36 (0.71) 4.31 (0.74) ´1.64
(4) People who have only one sexual partner have a low risk of
becoming infected with HPV 2.55 (1.02) 2.71 (0.99) 2.64 (1.01) ´1.65
(5) Using a condom can provide 100% protection against
HPV infection 3.93 (0.96) 4.06 (0.92) 4.00 (0.94) ´1.44
(6) Preventing HPV infection is important for men 3.72 (0.85) 3.72 (0.86) 3.72 (0.85) ´0.04
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Table 4. Cont.
Questions on Attitude towards HPV Vaccination
Males Females Total
t-Statistics
Mean (SD) Mean (SD) Mean (SD)
(7) Education on HPV should be implemented at school 4.12 (0.81) 4.26 (0.80) 4.19 (0.80) ´1.86
(8) Cervical cancer is not a big problem for women 4.11 (0.99) 4.34 (0.88) 4.23 (0.93) ´2.52 *
(9) Cervical cancer may cause death for women 4.03 (0.86) 4.18 (0.81) 4.11 (0.84) ´1.87
(10) Men can get involved to prevent their partner from getting
cervical cancer 3.88 (0.83) 3.91 (0.83) 3.89 (0.83) ´0.31
(11) Women are embarrassed to get a Pap test 2.79 (0.96) 3.02 (1.03) 2.91 (1.00) ´2.34 *
(12) HPV vaccination is not necessary because a Pap test can be
done to rule out cervical cancer 3.56 (0.95) 3.81 (0.91) 3.70 (0.93) ´2.76 **
(13) It is better to be vaccinated before becoming sexually active 3.85 (0.87) 4.04 (0.85) 3.95 (0.86) ´2.31 *
(14) It is preferable to vaccinate both men and women 3.96 (0.82) 4.04 (0.77) 4.00 (0.79) ´1.03
(15) I am well enough informed to request vaccination without
parental consent 3.33 (0.95) 3.43 (0.90) 3.38 (0.92) ´1.08
(16) I have sufficient information about HPV and its vaccine to
decide whether to receive the vaccine 3.08 (0.98) 3.18 (0.86) 3.13 (0.92) ´1.15
(17) Hong Kong adolescents need sex education 3.80 (0.82) 3.84 (0.84) 3.82 (0.83) ´0.44
(18) I am sure that the HPV vaccine is highly effective 3.40 (0.77) 3.43 (0.75) 3.42 (0.76) ´0.32
(19) I am sure that the HPV vaccine is safe 3.40 (0.82) 3.40 (0.80) 3.40 (0.81) 0.08
(20) I need extra information about the efficacy of the
HPV vaccine 2.15 (0.88) 2.13 (0.73) 2.14 (0.80) 0.31
(21) HPV vaccination can lead to an increase in risky
sexual behavior 3.24 (0.89) 3.38 (0.87) 3.32 (0.88) ´1.76
* p < 0.05; ** p < 0.01.
3.6. Knowledge of HPV Vaccination
Regarding knowledge of HPV vaccination, it was found that a high proportion of questions were
answered incorrectly. In particular, there were five questions that received a correct response from less
than one-third of the respondents. The questions were: “(1) More than 50% of sexually active women
in Hong Kong have been infected with HPV once in their life” (14% correct); “(2) More than 50% of
sexually active men in Hong Kong have been infected with HPV once in their life” (8.9% correct); “(7)
Having a single sexual partner can prevent HPV infection” (24.9% correct); “(12) HPV that causes
cervical cancer and genital warts is the same type” (30% correct); and “(15) Women over the age of 50
should start to get a Pap test” (26.5%) (Table 5).
Int. J. Environ. Res. Public Health 2016, 13, 486 10 of 16
Table 5. Gender differences in knowledge of HPV vaccination.
Question Type Questions on HPV and HPV Vaccination
Correctly Answered
χ2Males Females Total
n (%) n (%) n (%)
Questions on HPV
(1) More than 50% of sexually active women in Hong Kong have
been infected with HPV once in their life 34 (16.7) 27 (11.5) 61 (14.0) 2.46
(2) More than 50% of sexually active men in Hong Kong have been
infected with HPV once in their life 21 (10.3) 18 (7.7) 39 (8.9) 0.94
(3) You get HPV infection only through having sex. 140 (69.0) 166 (70.9) 306 (70.0) 0.20
(4) Using condoms can completely prevent HPV infections 151 (74.4) 183 (78.2) 334 (76.4) 0.88
(5) HPV can cause cervical cancer 153 (75.4) 175 (74.8) 328 (75.1) 0.02
(6) Normally, you do not have any signs and symptoms when you
get an HPV infection 80 (39.4) 95 (40.6) 175 (40.0) 0.06
(7) Having a single sexual partner can prevent HPV infection 51 (25.1) 58 (24.8) 109 (24.9) 0.01
(8) HPV can cause genital warts 117 (57.6) 119 (50.9) 236 (54.0) 2.01
(9) HPV infection occurs only in women 149 (73.4) 181 (77.4) 330 (75.5) 0.92
(10) Early sexual activity is a risk factor for HPV infection 101 (49.8) 123 (52.6) 224 (51.3) 0.34
(11) A Pap test is a kind of cervical cancer treatment 96 (47.3) 125 (53.4) 221 (50.6) 1.63
(12) The HPV that causes cervical cancer and genital warts is of the
same type 64 (31.5) 67 (28.6) 131 (30.0) 0.43
(13) Cervical cancer can be detected in the early stage 142 (70.0) 153 (65.4) 295 (67.5) 1.03
(14) Persistent infections of HPV can cause cervical cancer 113 (55.7) 126 (53.8) 239 (54.7) 0.15
(15) Women over the age of 50 should start to get a Pap test 49 (24.1) 67 (28.6) 116 (26.5) 1.13
Questions on HPV
vaccination
(16) There is a vaccine to protect against cervical cancer and
genital warts 117 (57.6) 141 (60.3) 258 (59.0) 0.31
(17) The HPV vaccine is currently recommended for women only 124 (61.1) 142 (60.7) 266 (60.9) 0.01
(18) Women who were vaccinated against HPV do not need to get
a Pap test 122 (60.1) 164 (70.1) 286 (65.4) 4.79 *
(19) The HPV vaccine is recommended for males and females of
every age group 71 (35.0) 89 (38.0) 160 (36.6) 0.44
(20) It is good to get vaccinated against HPV after becoming
sexually active 97 (47.8) 144 (61.5) 241 (55.1) 8.32 **
(21) The HPV vaccine is available in Hong Kong now 163 (80.3) 206 (88.0) 369 (84.4) 4.95 *
(22) The HPV vaccine can provide 100% protection against
HPV-related diseases 153 (75.4) 196 (83.8) 349 (79.9) 4.76 *
* p < 0.05; ** p < 0.01.
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Significant gender differences were seen in the responses to the following four questions: “(18)
Women who were vaccinated against HPV do not need to get a Pap test” (males 60.1% vs. females
70.1%, p < 0.05); “(20) It is good to get vaccinated against HPV after becoming sexually active” (males
47.8% vs. females 61.5%, p < 0.01); “(21) The HPV vaccine is available in Hong Kong now” (males
80.3% vs. females 88.0%, p < 0.05); and “(22) The HPV vaccine can provide 100% protection against
HPV-related diseases” (males 75.4% vs. females 83.8%, p < 0.05) (Table 5).
3.7. Predictors of the Respondents’ Attitude towards HPV Vaccination
After the univariate analysis, a multivariate linear regression analysis was performed on those
variables that correlated with the respondents’ total score for attitude in the bivariate analysis with
a p-value of smaller than 0.1. The final regression model included 10 predictors. Three of them were
on gender, the acceptable maximum price of the vaccine when the efficacy is 100% for cervical cancer
and genital warts, and the willingness to receive the HPV vaccine if it can protect against cervical/anal
cancer and genital warts. The regression coefficients showed that female students, students willing
to receive the HPV vaccine, and students who would pay a higher acceptable maximum price were
likely to have a better attitude towards HPV vaccination. The remaining seven predictors were about
the correctness of answering questions related to the HPV vaccine. All seven predictors indicated
that students who correctly answered the questions had a better attitude towards HPV vaccination.
The overall adjusted R2 of the regression model was 0.33, which was considered large (Table 6) [35].
The variance inflation factor (VIF) of all of the variables was less than 10, which suggested that there
was no co-linearity problem [36].
Table 6. Predictors of the respondents’ attitude towards receiving the HPV vaccine.
Predictors B 95% CI t-Value VIF adj-R2
(1) Gender (0: female; 1: male) ´1.40 (´2.48, ´0.33) ´2.57 * 1.05
0.33
(2) Acceptable maximum price of the vaccine when the efficacy is 100% for
cervical cancer and genital warts (1: <$500; 7: >$1500) 0.35 (0.04, 0.66) 2.22 * 1.07
(3) Willingness to receive the HPV vaccine if it can protect against cervical/anal
cancer and genital warts (1: I would like to be vaccinated; 2: I cannot make
a decision; 3: I would not like to be vaccinated)
´1.90 (´2.57, ´1.24) ´5.60 *** 1.04
Knowledge of
vaccination
(4) HPV infection occurs only in women (0: incorrect or don’t
know; 1: correct) 2.18 (0.78, 3.58) 3.06 ** 1.31
(5) Persistent HPV infections can cause cervical cancer
(0: incorrect or don’t know; 1: correct) 1.90 (0.74, 3.07) 3.22 ** 1.23
(6) The use of condoms can completely prevent HPV infection
(0: incorrect or don’t know; 1: correct) 2.30 (1.01, 3.60) 3.49 ** 1.09
(7) The HPV vaccine is currently recommended only for
women (0: incorrect or don’t know; 1: correct) 1.94 (0.72, 3.17) 3.12 ** 1.31
(8) It is good to get vaccinated against HPV after becoming
sexually active (0: incorrect or don’t know; 1: correct) 1.76 (0.65, 2.87) 3.12 ** 1.12
(9) More than 50% of sexually active women in Hong Kong
have been infected with HPV once in their life (0: incorrect
or don’t know; 1: correct)
2.09 (0.56, 3.61) 2.69 ** 1.05
(10) There is a vaccine to protect against cervical cancer and
genital warts (0: incorrect or don’t know; 1: correct) 1.36 (0.19, 2.53) 2.29 * 1.20
* p < 0.05; ** p < 0.01; *** p < 0.001.
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4. Discussion
4.1. Low HPV Vaccination Uptake Compared to Similar Studies
In this study, the HPV vaccination rate of the Hong Kong undergraduates was estimated to be
13.3%. This is significantly lower that found than in some developed countries like Portugal and the
United Kingdom, at about 80% and 81%, respectively [37]. This phenomenon could be related to
vaccination subsidies, as countries that have set up an HPV vaccination program offering the vaccine
at a low cost would have a high vaccination rate. This is also consistent with the result of this study,
which found that most people would prefer to pay less than HK$500 to be vaccinated, regardless of the
efficacy of the vaccine. A lower price might increase the intention to get vaccinated. Furthermore, the
vaccination rate in this study is consistent with that found in studies conducted in countries that do not
have a vaccination subsidy program. For example, Bang et al. found that 12% of university students in
Seoul had been vaccinated against HPV [38]. To raise the HPV vaccination rate, the government may
need to consider subsidizing the vaccination.
4.2. Intention of Vaccination
In this study, the figure for students who reported that they intended to get vaccinated against
HPV was 69.6%, which is considered modest. A similar study conducted in Korea reported a similar
HPV vaccination intention of 62.8% [28]. This modest intention was probably related to a relative
knowledge deficit, as more knowledge increases the intention to be vaccinated. Another reason why
young adults might be reluctant to receive the HPV vaccine to prevent sexually transmitted diseases is
that young adults may be afraid of being labeled sexually active. A previous Asian study reported that
young women were worried that getting vaccinated against HPV would give others the impression
that they were sexually active [39]. On the other hand, Giuseppe et al. in Italy reported that a higher
intention to receive HPV vaccination was associated with more openness to sex-related topics [40].
4.3. Knowledge of HPV and HPV Vaccination
In general, the knowledge of undergraduate students regarding HPV and HPV vaccination was
poor. The mean percentage of correct answers to questions about HPV was only 52.7% in this study,
which was lower than a previous study conducted in the U.S. [41]. Dillard and Spear interviewed
396 undergraduate female students aged 18–24 and reported a mean correct knowledge score of
65%. The relatively low level of knowledge is probably related to the little coverage that is given to
HPV in sex education programs in Hong Kong. This study also showed that students studying in
programs unrelated to healthcare were able to answer fewer questions correctly compared to those in
healthcare-related disciplines. Students studying subjects related to healthcare have learned about
cervical cancer and would have acquired more knowledge about the causes of such diseases as cancer.
The significantly higher scores of students studying healthcare-related disciplines might imply that
better education is effective at improving the knowledge and attitudes of students about the uptake of
HPV vaccination.
4.4. Predictors of Students’ Attitude towards HPV Vaccination
In this study, the most significant positive predictors of the students’ attitude towards HPV
vaccination were those related to their knowledge of HPV and HPV vaccination. Seven out of ten
significant predictors identified from the regression analysis were related to the knowledge test (Table 6).
Janz and Backer noted that high perceived susceptibility, perceived severity, and perceived benefits
may trigger health-promoting behaviors and change people’s attitude towards taking health-related
actions. Students with poorer knowledge about HPV infection and vaccination are believed to have
a lower perception of the risk and severity of HPV infection, and a lower perception of the benefits
of HPV vaccination [42]. According to the Health Belief Model [43], a poorer level of knowledge
among the respondents may indicate a lower intention of getting vaccinated against HPV. This finding
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explained the low vaccination rate of the respondents in the study. In contrast, a study showed that
the intention to get vaccinated increased from 35% to 69% after the participants read an information
pamphlet on the subject [44]. Knowledge is an important predicator of vaccination rates. On the other
hand, in the final regression model there was a significant predictor related to acceptability, which
was the maximum acceptable price of the HPV vaccine. In addition to the level of knowledge about
the vaccine, it is also important to keep the price of the vaccine at an affordable level in relation to
its efficacy.
Among the male students, the injection rate of the HPV vaccine was only 0.5%. The results
of the regression analysis also indicate that gender is a significant factor affecting attitudes toward
HPV vaccination. The health promotion efforts on preventing HPV infection have mainly focused
on cervical cancer, which is not related to the health of males. Male students may not know about
the connection between HPV infection and genital warts. With a lower level of knowledge, they may
be less aware of the full potential impact of HPV infection to themselves as males, and the benefits
of vaccination.
4.5. Limitations
First, as convenience sampling was used and all of the respondents were from the same university,
the results may not be representative enough for the findings to be generalizable to the entire
population [45]. Students with family history of cervical cancer or other HPV-related health issues
were not excluded from the study, which may contaminate the results because they are expected to
have a different belief and behavioral pattern on HPV vaccination. Another limitation of this study
was that only the English version of the questionnaires was provided to the participants. There were
some medical terms such as the Pap test, sexology, and genital warts, which may have been difficult
for students in disciplines unrelated to healthcare to understand, and this may have led to some
misunderstanding of the questions and affected results of the study. Furthermore, the questionnaires
did not include questions related to homosexual relationships. A study by Gutierrez et al. found
that men who have sex with men (MSM) are at a higher risk of contracting HPV than heterosexual
men, and a higher perceived susceptibility among this group should be anticipated. The study also
found that MSM were more capable of getting the HPV vaccine than heterosexual men [46]. In
addition, the question on relationship status could be adjusted by including more levels such as
married and divorced. Questions such as that on the number of sexual partners could also be included
to obtain a better understanding of the information relating to the sexual experience of the participants.
Moreover, questions relating to the three-dose requirement for HPV and whether this is a barrier
should also be included. Finally, this study only examined the attitudes of the participants toward
HPV vaccination, but their intention may not reflect their actual practice or behaviors.
4.6. Recommendations
This study found that male undergraduate students have a lower perception of the risks of HPV
infection, which may be due to a knowledge deficit. Public health professionals and policy makers
should conduct better health promotion efforts in universities based on the factors and knowledge
deficit that have been identified, in order to increase HPV vaccination among undergraduate students.
Promotion of HPV vaccination may be delivered through an online platform or on television, which,
according to the results of this study, are the two most common channels through which information
about HPV is acquired. The health promotion activities should also focus more on male vaccination,
due to the very low male vaccination rate. Emphasizing the link between HPV infections and genital
warts may draw more attention from males than emphasizing cervical cancer only. The government
might also provide some financial subsidies, which could increase the willingness of students to get
vaccinated. A vaccination promotion program and registry should be established, thus providing
a more reliable source of HPV vaccination rate and statistics. Further studies could be carried out to
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investigate factors affecting the attitudes towards vaccination of people in homosexual relationships,
e.g., MSM.
5. Conclusions
The knowledge and awareness of local undergraduate students in Hong Kong concerning HPV
infection is not high and their HPV vaccination rate is relatively low. More aggressive education and
promotion activities on HPV and HPV vaccination should be organized for undergraduates, especially
for male students, as their knowledge and attitude towards the subject is poorer than that of female
students. Awareness of HPV infection should be promoted among male students.
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